Clinical Evaluation of Certain Ayurvedic Formulations in the Management of Sthoulya (Obesity)

Central Council for Research in Ayurvedic Sciences0 个研究点目标入组 0 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•1.Patients of either sex with age above 25years and below 60 years.
•2.Obese patient having 20% excess weight than desirable weight according to height, sex and age / age adjusted BMI above 85th percentile (Indian standard)
•3.WHR- Waist Hip circumference Ratio > 0.95 in males & > 0.8 in females.

•1.Age below 25 years and above 60 years
•2.Obesity secondary to or associated with Hypothyroidism, Hyper tension, Diabetes mellitus, Hyperlipidemia or Cushingâ??s syndrome.
•3.Pregnancy and lactation.
•4.Patients who cannot report in person once in 2 weeks in the OPD
•5.Patients with poorly controlled Hypertension ( >160/100 mmHg)
•6.Patients with poorly controlled Diabetes Mellitus having Hb A1C of > 8
•7.Patients who have a past history of Arterial Fibrillation, Acute Coronary Syndrome, Myocardial Infarction, Stroke or Severe Arrhythmia in the last 6 months.
•8.Symptomatic patient with clinical evidence of Heart failure.
•9.Known HIV & Viral Hepatitis positive cases
•10.Patients with concurrent serious hepatic disorder (defined as Aspartate Amino Transferase (AST) and / or Alanine Amino Transferase (ALT), Total Bilirubin, Alkaline Phosphatase (ALP) > 2 times upper normal limit) or Renal Disorders (defined as S. Creatinine >1.2mg/dl), Severe Pulmonary Dysfunction (uncontrolled Bronchial Asthma and / or Chronic Obstructive Pulmonary Disease [COPD]), or any other condition that may jeopardize the study.
•11.Alcoholics, smokers, and/or drug abusers
•12.H/o hypersensitivity to any of the trial drugs or their ingredients
•13.Patients who have completed participation in any other clinical trial during the past six months.
•14.Any other condition which the Investigator thinks may jeopardize the study.

发起方